CSIMarket
 
Principia Biopharma Inc   (NASDAQ: PRNB)
 

Principia Biopharma Inc's Customers Performance

PRNB



 
PRNB's Source of Revenues During the corresponding time, Principia Biopharma Inc recorded a revenue increase by 66.67 % year on year, While revenue at the Principia Biopharma Inc 's corporate clients

• List of PRNB Customers




for the same period Principia Biopharma Inc recorded revenue increase by 66.67 % year on year,

• List of PRNB Customers

Principia Biopharma Inc's Business Units






Principia Biopharma Inc's Comment on Sales, Marketing and Customers
















PRNB's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Principia Biopharma Inc 3,532.96 35.16 0.00 100
SUBTOTAL 0.00 0.00 0.00 -

Sources: Principia Biopharma Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Principia Biopharma Inc’s corporate clients.
For your research, we’ve provided 9 tables on Principia Biopharma Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.